National Agricultural Research OrganisationOur InstitutesOpportunitiesContact

NAROVAC Vaccine

NAROVAC Vaccine was released in 2025. Kills up to 90% of the Brown ear tick (R. appendiculatus), It has 100% efficacy against ECF causing ticks

Technology codeNAROVAC Vaccine
Lead instituteNaLIRRI
ReadinessReleased
IP status
NAROVAC Vaccine

Problem addressed

The 3 types of notorious ticks (Bont legged tick, Brown ear tick and blue tick)


About this technology

Controls the 3 types of notorious ticks (Bont legged tick, Brown ear tick and blue tick)
It has 100% efficacy against ECF causing ticks
Kills up to 90% of the Brown ear tick (R. appendiculatus)
Reduces deaths in cattle and calves
Saves a farmer UGX 188,000 per cow/year
It is a cheaper vaccine given only 3 times (at Day 0, Day 30 and after 6 months) followed by once a year compared to accaricides which are given to the animal every week
Reduces labour costs during treatment

Performance and benefits

KEY PERFORMANCESaves a farmer UGX 188,000 per cow/year

Saves a farmer UGX 188,000 per cow/year
It is a cheaper vaccine given only 3 times
Reduces labour costs during treatment
It has 100% efficacy against ECF causing ticks

Where it is suitable

Agro-ecological zonesCountry wide
DistrictsCountry wide
Target usersLivestock Farmers
Value-chain stage

Application guidance

Requires three initial doses given on Day 0, Day 30, and Day 180, followed by an annual booster to maintain protection for a full year

Research evidence

The primary multi-site field trial calculated a total integrated vaccine efficacy/effectiveness of 98.8% under real-world field conditions.

View related evidence →
PARTNER • LICENSE • INVEST

Take Ugandan innovation further.

Access investment-ready technologies and research partnerships.

View opportunitiesPartner with NARO